Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
Power TOST question Power TOST question Power TOST question Total sample size vs. vector of groups sizes	Achievwin	2024-02-20 19:49	3	2024-02-23 10:06	881
sampleN.TOST vs. sampleN.scABEL ABEL is a framework (decision scheme) ABEL is a framework (decision scheme) ABEL vs. ABE ABEL vs. ABE Being able to read does not hurt… Being able to read does not hurt… Being able to read does not hurt… Vet BE Guideline	BEQool	2024-01-29 11:53	8	2024-02-05 16:49	1,360
Go/No-go Decision for Pivotal Study Problematic T/R-ratio… TSD? sample size for TSD is better than for 1SD?	NK	2023-12-27 12:15	3	2024-01-01 19:54	1,387
Sequential Sample Size and Power Estimate in R IUT IUT power is analytically accessible Power<50% Power<50% Power<50%	xpresso	2023-09-19 13:40	6	2024-03-01 23:02	2,043
FDA: PD BE study FDA: PD BE study	balakotu	2023-07-12 04:24	1	2023-07-13 08:45	1,621
Sample size estimation for parallel design with more than 2 treatments Sample size estimation for parallel design with more than 2 treatments >2 treatments, multiplicity or not >2 treatments, multiplicity or not	BEQool	2023-05-24 21:05	3	2023-05-29 10:41	1,609
Sample Size Benefits of Replicate Design with ABE Sample Size Benefits of Replicate Design with ABE Dropouts less problematic	Sereng	2023-05-24 15:41	2	2023-05-25 16:27	1,455
R Validation R Validation R Validation R Validation	Imph	2023-05-14 13:48	3	2023-05-15 13:42	1,476
Sample size for replicate crossover studies Sample size for replicate crossover studies Sample size for replicate crossover studies Sample size for replicate crossover studies	Imph	2023-03-06 14:29	3	2023-03-07 11:30	1,885
Deconvolution sample size and design issues Deconvolution sample size and design issues Deconvolution sample size and exponential terms Deconvolution sample size and exponential terms	mittyri	2023-02-09 14:40	3	2023-02-10 09:34	2,006
Bioequivalence Across 3 Different Injection Site Bioequivalence Across 3 Different Injection Site Bioequivalence Across 3 Different Injection Site Two at a Time Two at a Time Two at a Time	XH7081	2022-09-21 20:22	5	2022-09-23 09:03	2,561
N calculation for trial about PK superiority Bracketing approach SmPC change is the whole thing N calculation for trial about PK superiority The efocus is faster absorption The efocus is faster absorption Non-parametric N Non-parametric N Non-parametric N	alejandro_jo1990	2022-09-01 14:40	8	2022-09-15 12:56	2,711
Sample size for 3-way crossover Sample size for 3-way crossover Sample size for 3-way crossover AND or OR, that’s the question AND or OR, that’s the question AND or OR, that’s the question AND or OR, that’s the question AND or OR, that’s the question AND or OR, that’s the question The unknown ρ	chrisk	2022-08-09 18:55	9	2022-08-17 13:04	5,498
3 treatments with two-at-a-time approach 3 treatments with two-at-a-time approach 3 treatments with two-at-a-time approach	chrisk	2022-08-01 07:03	2	2022-08-01 15:56	2,493
BCS Class II & IV molecule BCS Class II & IV molecule BCS Class II & IV molecule in vivo ≠ in vitro in vivo ≠ in vitro in vivo ≠ in vitro in vivo ≠ in vitro Assumptions Assumptions	Mithu	2022-07-25 06:39	8	2022-07-25 11:26	2,333